
Tatva Chintan Pharma Chem Ltd is Rated Hold
2026-11-14 10:10:28Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 22 October 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with the latest comprehensive analysis.
Read MoreTatva Chintan Pharma Chem Ltd Falls 18.98%: 5 Key Factors Driving the Sharp Weekly Decline
2026-10-24 12:01:30Key Events This Week Oct 19: Stock opens at Rs.1,900.05, down 2.08% Oct 21: New 52-week high of Rs.2,109.95 reached Oct 22: Sharp intraday low amid heavy price pressure Oct 23: Downgrade to Hold and technical momentum shift Oct 23: Week closes at Rs.1,572.10, down 18.98% Week OpenRs.1,940.40 <div class="...
Read More
Tatva Chintan Pharma Chem Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals
2026-10-23 08:42:27Tatva Chintan Pharma Chem Ltd, a specialty chemicals company, has seen its investment rating downgraded from Buy to Hold as of 22 Oct 2026. This adjustment reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite outstanding quarterly financial results, the stock’s recent price performance and technical signals have moderated investor enthusiasm, prompting a more cautious stance.
Read More
Tatva Chintan Pharma Chem Ltd Sees Technical Momentum Shift Amid Market Volatility
2026-10-23 08:06:26Tatva Chintan Pharma Chem Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum following a sharp price correction. The stock’s recent downgrade from a Buy to a Hold rating reflects evolving market dynamics and mixed technical signals, underscoring the need for investors to carefully analyse the underlying trends and momentum indicators.
Read More
Tatva Chintan Pharma Chem Ltd is Rated Buy
2026-10-09 10:10:40Tatva Chintan Pharma Chem Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1920
2026-10-07 10:01:21Surging to a new 52-week high of Rs 1920 on 7 Oct 2026, Tatva Chintan Pharma Chem Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market despite a bearish backdrop for the Sensex. The stock’s recent rally is underpinned by a confluence of bullish technical indicators and sustained upward price action across multiple timeframes.
Read More
Broad-Based Technical Strength Lifts Tatva Chintan Pharma Chem Ltd to 52-Week High of Rs 1895
2026-10-06 15:42:50Surging to an intraday peak of Rs 1895 on 6 Oct 2026, Tatva Chintan Pharma Chem Ltd has marked a significant milestone by hitting a fresh 52-week high. This rally, underpinned by a strong alignment of technical indicators and sustained price momentum, has propelled the stock well ahead of its sector and broader market peers.
Read More
Tatva Chintan Pharma Chem Ltd is Rated Buy by MarketsMOJO
2026-09-28 10:10:37Tatva Chintan Pharma Chem Ltd is rated Buy by MarketsMOJO. This rating was last updated on 16 September 2026, reflecting a shift from the previous Hold status. However, the analysis and financial metrics presented here are based on the company’s current position as of 28 September 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read MoreTatva Chintan Pharma Chem Ltd Gains 10.20%: 5 Key Factors Driving the Week’s Momentum
2026-09-19 12:00:05Key Events This Week 15 Sep: Stock declines 3.73% amid technical momentum shift 16 Sep: Intraday high reached with 7.32% surge 17 Sep: Mojo Grade upgraded to Buy following strong financials 18 Sep: Continued gains close week at Rs.1,769.40 (+3.83%) Week OpenRs.1,605.65 Week CloseRs.1,769.40</di...
Read MoreIntimation Regarding Cancellation Of Schedule Of Earnings Call
19-Oct-2026 | Source : BSEEarnings Call scheduled to be held on Monday 19 October 2026 at 05:00 p.m. (IST) has been cancelled due to unforeseen circumstances.
Updated Investor Presentation
19-Oct-2026 | Source : BSEUpdated Investor Presentation.
Announcement under Regulation 30 (LODR)-Investor Presentation
19-Oct-2026 | Source : BSEInvestor Presentation for the quarter and half year ended 30 September 2026.
Corporate Actions
No Upcoming Board Meetings
Tatva Chintan Pharma Chem Ltd has declared 20% dividend, ex-date: 11 Sep 26
No Splits history available
No Bonus history available
No Rights history available